Asthma Medications and Biologic Therapies Quiz
40 Questions
4 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the primary guideline for treatment of asthma?

  • Using short-acting beta-adrenergic agonists for immediate relief
  • Using corticosteroids for immediate relief
  • Using leukotriene antagonists for long-term control
  • Using long-acting beta-adrenergic agonists for long-term control (correct)
  • What is the basic mechanism of action of antitussive agents?

  • Cough suppression (correct)
  • Inflammation reduction
  • Mucous membrane irritation
  • Bronchodilation
  • Which medication is indicated for immediate relief of asthma symptoms?

  • Corticosteroids
  • Long-acting anticholinergics
  • Leukotriene antagonists
  • Short-acting beta-adrenergic agonists (correct)
  • What are the adverse effects of long-term use of supraphysiologic doses of steroids?

    <p>Hyperglycemia and osteoporosis</p> Signup and view all the answers

    What is the recommended interval for administering Ipratropium Br 0.5mg?

    <p>Every 30 minutes X 3 then q 2-4 hrs prn</p> Signup and view all the answers

    What should be monitored in patients with severe respiratory distress unresponsive to medications?

    <p>FEV1 or PEF, O2 saturation and pulse</p> Signup and view all the answers

    When should patients be evaluated for a change in controller medications?

    <p>If patients have asthma symptoms or need a rescue inhaler more than twice a week</p> Signup and view all the answers

    What should be assessed before making a change in medication for asthma patients?

    <p>Technique and adherence in using inhalers</p> Signup and view all the answers

    Which type of medication is the most effective bronchodilator available?

    <p>Beta-2 agonists</p> Signup and view all the answers

    What is the duration of bronchodilation provided by long-acting LABAs like Formoterol?

    <p>4-8 hours</p> Signup and view all the answers

    For which symptoms are LABAs preferred?

    <p>Nighttime symptoms</p> Signup and view all the answers

    What are the adverse effects of beta-2 agonists?

    <p>Heart rate, tremor, hypokalemia</p> Signup and view all the answers

    Which type of medication is the most effective anti-inflammatory agent for asthma?

    <p>Inhaled corticosteroids (ICS)</p> Signup and view all the answers

    What are the preferred symptoms for daily maintenance therapy with ICS?

    <p>Daytime symptoms</p> Signup and view all the answers

    What are the adverse effects of ICS?

    <p>Oral candidiasis, dysphonia</p> Signup and view all the answers

    When are systemic corticosteroids indicated for asthma exacerbations?

    <p>Significant exacerbations</p> Signup and view all the answers

    What type of therapy is Omalizumab (Xolair)?

    <p>Anti-IgE therapy</p> Signup and view all the answers

    For which type of asthma is Omalizumab used?

    <p>Severe asthma with poor ICS control</p> Signup and view all the answers

    Which biologic therapy is indicated for severe asthma patients with an eosinophilic phenotype and is administered via IV infusion every 4 weeks?

    <p>Reslizumab</p> Signup and view all the answers

    Which biologic therapy is an interleukin-5 receptor antagonist and is an add-on therapy for severe eosinophilic asthma, administered subcutaneously?

    <p>Benralizumab</p> Signup and view all the answers

    Which biologic therapy blocks the effects of IL-4 and is used to reduce exacerbations and improve lung function in moderate-to-severe eosinophilic asthma patients, administered subcutaneously every other week?

    <p>Dupilumab</p> Signup and view all the answers

    Which biologic therapy is indicated to reduce exacerbations in severe asthma patients with blood eosinophil counts of 150/microL or greater, administered subcutaneously?

    <p>Mepolizumab</p> Signup and view all the answers

    Which biologic therapy is an add-on maintenance medication for moderate to severe asthma in adults and children over 6 years old with poorly controlled symptoms and allergic sensitization?

    <p>Omalizumab (Xolair)</p> Signup and view all the answers

    Which biologic therapy is an add-on maintenance treatment for severe asthma in adult and pediatric patients over 12 years old, administered subcutaneously every 4 weeks?

    <p>Tezepelumab</p> Signup and view all the answers

    Which biologic therapy is not recommended for patients with parasitic, especially helminthic, infections?

    <p>Mepolizumab</p> Signup and view all the answers

    What is the classification and management of asthma severity based on?

    <p>Impairment and risk categories</p> Signup and view all the answers

    What does the treatment for severe asthma include?

    <p>High-dose inhaled glucocorticoid and long-acting beta agonist (LABA) or leukotriene modifier/theophylline</p> Signup and view all the answers

    What is the home management of mild to moderate asthma exacerbations involve?

    <p>Using SABA beta2 agonists or GC-formoterol for acute symptom relief, with reassessment and appropriate actions based on response</p> Signup and view all the answers

    Which of the following is a goal of asthma treatment?

    <p>Minimizing medication side-effects</p> Signup and view all the answers

    Which aerosol delivery device does not contain propellant?

    <p>Soft Mist Inhalers (SMIIs)</p> Signup and view all the answers

    What is the primary cause of acute inflammation in asthma?

    <p>Viral infection</p> Signup and view all the answers

    Which type of inhaler requires shaking and pressing during inhalation?

    <p>Metered Dose Inhalers (MDIs)</p> Signup and view all the answers

    What is the role of IgE in asthma?

    <p>Causing mast cells and lymphocytes to become activated and sensitized</p> Signup and view all the answers

    Which type of inhaler requires breath-actuation for drug delivery?

    <p>Dry Powder Inhalers (DPIs)</p> Signup and view all the answers

    What is the primary cause of chronic inflammation in asthma?

    <p>Allergens</p> Signup and view all the answers

    Which type of inhaler achieves higher pulmonary deposition than MDIs?

    <p>Soft Mist Inhalers (SMIIs)</p> Signup and view all the answers

    What is the primary cause of airflow obstruction in asthma?

    <p>Bronchoconstriction</p> Signup and view all the answers

    Which type of inhaler is used to produce an aerosol from liquid for efficient drug delivery?

    <p>Nebulizers</p> Signup and view all the answers

    What is the primary role of parasympathetic (vagal) stimulation in the airway?

    <p>Providing normal resting airway tone</p> Signup and view all the answers

    What is the primary cause of sensitization of mast cells and lymphocytes in asthma?

    <p>Allergens</p> Signup and view all the answers

    Study Notes

    Asthma Medications Overview

    • Medications for asthma include beta-2 agonists, glucocorticosteroids, leukotriene blockers, mast cell stabilizers, methylxanthines, and biologic agents.
    • Beta-2 agonists are the most effective bronchodilators available, with short-acting (SABA) names like Albuterol and Levalbuterol.
    • Long-acting LABAs like Formoterol and Salmeterol provide 4-8 hours and 24-hour duration of bronchodilation, respectively.
    • LABAs are not for acute attacks and are preferred for nighttime symptoms, but have labeling risks and warnings associated with long-acting beta agonists.
    • Other beta agonists include Terbutaline, Isoproterenol, and Epinephrine, each with specific uses and effects.
    • Adverse effects of beta-2 agonists include heart rate, tremor, nervousness, hypokalemia, and tolerance with chronic use.
    • Inhaled corticosteroids (ICS) are the most effective anti-inflammatory agents for asthma, improving responsiveness to beta2 agonists and lung function.
    • ICS are preferred for daily maintenance therapy and have low, medium, and high dose regimens, with adverse effects like oral candidiasis and dysphonia.
    • The prescription of low-dose ICS-formoterol involves specific steps based on severity, with as-needed doses before exercise or allergen exposure.
    • Systemic corticosteroids are indicated for significant asthma exacerbations and have adverse effects like headache, palpitations, and tachycardia.
    • Biologics for asthma include anti-IgE therapy like Omalizumab (Xolair), a monoclonal antibody administered via subcutaneous injection based on IgE levels and weight.
    • Omalizumab is used for moderate to severe asthma with poor ICS control.

    Biologic Therapies for Severe Asthma and Management

    • Omalizumab (Xolair) is an add-on maintenance medication for moderate to severe asthma in adults and children over 6 years old with poorly controlled symptoms and allergic sensitization.
    • Common adverse effects of Omalizumab include pain at injection, headache, and upper respiratory infections, with rare cases of anaphylaxis.
    • Mepolizumab, a monoclonal antibody to IL-5, is indicated to reduce exacerbations in severe asthma patients with blood eosinophil counts of 150/microL or greater, administered subcutaneously.
    • Reslizumab, a monoclonal anti-IL-5 antibody, is indicated as an add-on maintenance therapy for severe asthma in patients over 18 years old with an eosinophilic phenotype, given via IV infusion every 4 weeks.
    • Benralizumab, an interleukin-5 receptor antagonist, is an add-on therapy for severe eosinophilic asthma, administered subcutaneously.
    • Dupilumab, which blocks the effects of IL-4, is used to reduce exacerbations and improve lung function in moderate-to-severe eosinophilic asthma patients, administered subcutaneously every other week.
    • Tezepelumab (Tezspire), a monoclonal antibody, is an add-on maintenance treatment for severe asthma in adult and pediatric patients over 12 years old, administered subcutaneously every 4 weeks.
    • Biologics affecting eosinophils are not recommended for patients with parasitic, especially helminthic, infections.
    • The Global Initiative for Asthma classifies and manages asthma severity and control based on impairment and risk categories, determining changes in therapy.
    • The classification and management of asthma severity includes well controlled, not well controlled, and very poorly controlled categories, with corresponding treatment steps.
    • The treatment for severe asthma includes high-dose inhaled glucocorticoid and long-acting beta agonist (LABA) or leukotriene modifier/theophylline, and referral to an asthma specialist.
    • Home management of mild to moderate asthma exacerbations involves using SABA beta2 agonists or GC-formoterol for acute symptom relief, with reassessment and appropriate actions based on response.

    Asthma Treatment and Management

    • Atopy refers to the genetic susceptibility to produce IgE directed toward common environmental allergens.
    • IgE causes mast cells and lymphocytes to become activated and sensitized when challenged by allergens, leading to the release of inflammatory mediators.
    • The pathophysiology of asthma involves airflow obstruction with edema, bronchoconstriction, hypersecretion, and inflammation.
    • Acute inflammation in asthma can be provoked by unknown or known factors such as viral infection, allergens, and irritants.
    • Chronic inflammation in asthma involves various cells and clinical consequences like chronic airway hyperreactivity and airway remodeling.
    • Parasympathetic (vagal) stimulation provides normal resting airway tone, while catecholamines such as epinephrine cause bronchodilation via activation of Beta-2 receptors on bronchial smooth muscle.
    • Treatment of asthma involves aerosol delivery devices, including nebulizers, metered dose inhalers (MDIs), dry powder inhalers (DPIs), and soft mist inhalers (SMIIs).
    • Nebulizers, both jet and ultrasonic, are used to produce an aerosol from liquid for efficient drug delivery, with the former requiring flow rates > 6L/Minute for effective delivery.
    • Metered Dose Inhalers (MDIs) are the most used and convenient delivery devices, requiring shaking and pressing during inhalation.
    • Dry Powder Inhalers (DPIs) are breath-actuated devices that deliver micronized drug particles and are used for several asthma medicines.
    • Soft Mist Inhalers (SMIIs) are larger than MDIs, do not contain propellant, and achieve higher pulmonary deposition than MDIs.
    • The goals of asthma treatment include symptom control, maintenance of normal lung function, prevention of flare-ups and asthma deaths, and minimizing medication side-effects, with various terminologies and regimens used in the treatment.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Asthma Rx 2023 (1) PDF

    Description

    Test your knowledge of asthma medications and biologic therapies with this comprehensive quiz. Explore the various types of medications, their mechanisms of action, dosage regimens, adverse effects, and the use of biologics in severe asthma management. Understand the pathophysiology of asthma, treatment delivery devices, and the goals of asthma treatment and management.

    More Like This

    Asthma Medications Quiz
    5 questions

    Asthma Medications Quiz

    UserReplaceableInspiration avatar
    UserReplaceableInspiration
    Asthma Medications Quiz
    10 questions

    Asthma Medications Quiz

    ReasonableAndradite avatar
    ReasonableAndradite
    Asthma Medications Flashcards
    8 questions
    Use Quizgecko on...
    Browser
    Browser